相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
Guillermo Prada-Ramallal et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
024. CHALLENGES IN RETROPERITONEAL FIBROSIS: A CASE SERIES
Deniz Demirdal et al.
RHEUMATOLOGY (2017)
New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage
Nadia Hamdy et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
Jean-Louis Montastruc et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis
Ingo Strack et al.
LABORATORY INVESTIGATION (2011)
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins
Florence van Hunsel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Defining 'Signal' and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions
Manfred Hauben et al.
DRUG SAFETY (2009)
Idiopathic Retroperitoneal Fibrosis Prospective Evaluation of Incidence and Clinicoradiologic Presentation
E. F. H. van Bommel et al.
MEDICINE (2009)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
Pharmacovigilance:: methods, recent developments and future perspectives
L. Harmark et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
An instructive example of a long-latency adverse drug reaction - sclerosing peritonitis due to practolol
Ronald D. Mann
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Novel statistical tools for monitoring the safety of marketed drugs
J. S. Almenoff et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists
Trond Kvernmo et al.
CLINICAL THERAPEUTICS (2006)
β-Blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with Diastolic heart failure
M Kobayashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
分享论文
